Houston CEO at center of $134M fraud case victim of armed home invasion

Wednesday, June 9, 2021
CEO at center of $134M fraud case victim of armed home invasion
Mohamed Mokbel is accused in a $134 million Medicare fraud case. Neighbors said this is the latest in a string of events bringing unwanted attention to their block.

HOUSTON, Texas (KTRK) -- Mohamed Mokbel, the pharmacy executive at the center of a multi-million dollar federal health care fraud investigation, was the victim of an armed home invasion.

His attorney, Charles Flood, confirmed to ABC13 the incident happened at his Afton Oaks home early Tuesday morning. It's the same $2 million home where federal investigators arrested Mokbel in March.

SEE ALSO: Feds arrest CEO at upscale Houston home he allegedly bought with defrauded funds

As the CEO of 4M Pharmaceuticals, which operated several retail pharmacies in Houston, Fort Worth and south Florida, he is accused in a $134 million Medicare fraud case.

READ MORE: Houston CEO at center of $134M fraud case to be released on home confinement

Days after he was arrested at his $2 million home, the CEO of a pharmaceutical company was granted bond. The video above, though, explains a new issue that he faces.

He was released on bond in March shortly after his arrest.

Houston police say four people in their 20s broke into the home where Mokbel has been living under house arrest, wearing an ankle monitor. Neighbors said this is the latest in a string of events bringing unwanted attention to their block.

"It's a little disturbing," said a neighbor who asked to remain anonymous. "We all on the street have known that he has had a little bit of a problem, but we never thought it would escalate to this. This has always been a very peaceful, safe neighborhood."

It's unclear if anything inside the home was taken. The Houston Police Department were not able to share much more about this ongoing investigation.

The pharmacy operation in question, 4M Pharmaceuticals, remains open in Houston with 70 to 90 employees.

Follow Shelley Childers on Facebook, Twitter and Instagram.